JPRN-jRCT1061220081招募中2 期
A Phase II study of the efficacy and safety of Perflubutane for predicting highly Tumor Infiltrating Lymphocytes in early breast cancer (AppTIL study)
Shigematsu Hideo0 个研究点目标入组 100 人开始时间: 2023年1月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Patients who are at least 18 years of age at the time of consent
- •2. Patients with histologically confirmed invasive breast cancer
- •3. Patients diagnosed with clinical stage I-IIIA
- •4. Patients scheduled for radical surgery
- •5. Patients with mass lesions evaluable by ultrasonography
- •6. Patients with ECOG PS 0-2
- •7. Patients who provide written consent for participation in this study
排除标准
- •1. Patients undergoing preoperative treatment for breast cancer
- •2. Patients with a history of breast cancer on the affected side
- •3. Patients with a history of hypersensitivity to perflubutane
- •4. Patients with allergy to eggs or egg products
- •5. Patients with arteriovenous shunts in the heart or lungs
- •6. Patients with serious cardiac or pulmonary disease
- •7. Patients deemed inappropriate by the principal investigator or subinvestigator
研究者
相似试验
招募中
2 期
A Phase II study of the efficacy and safety of Perflubutane for predicting highly Tumor Infiltrating Lymphocytes in early breast cancer (AppTIL study)JPRN-UMIN000050067Hiroshima University Hospital100
已完成
不适用
Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myelomaMultiple MyelomaJPRN-UMIN000010258Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine30
已完成
不适用
Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitisAcute cholecystitisJPRN-UMIN000002052Chiba University Graduate School of Medicine78
招募中
1 期
Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)Progressive GlioblastomaMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864CTIS2023-503938-52-00niversitaetsklinikum Heidelberg AöR66
已完成
2 期
Phase II analysis for efficacy and safety of perioperative pirfenidone (Pirespa) therapy for patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)non-small-cell lung cancer combined with idiopathic pulmonary fibrosisJPRN-UMIN000007774West Japan Oncology Group42